𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Flow cytometric detection of recombinant human granulocyte-colony stimulating factor binding to leukemic cells

✍ Scribed by Dr. Noriyuki Tatsumi; Takahisa Yamane; Izumi Tsuda; Kiyoshi Okuda; Watana Chaisiripoomkere

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
456 KB
Volume
7
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis

To examine binding of recombinant human granulocyte-colony stimulating factor to myeloid cells, the factor was labeled with fluorescein isothiocyanate, and incubated with blood specimens, which were then analyzed by flow cytometry. Neutrophils demonstrated an increased fluorescence, while lymphocytes were negative. These cell fractions were used as controls for cytometric binding assays of leukemic cells. Six patients with lymphocytic leukemia were negative in this assay. Ten of 15 patients with myelocytic leukemia were positive. All patients (n = 5) in myeloblastic crisis of chronic myelogenous leukemia were also positive. The flow cytometry results correlated well with the results of colony formation in response to granulocyte-colony stimulating factor. The results indicate that our method is useful in predicting the susceptibility of leukemic cells to recombinant growth factors.

πŸ“œ SIMILAR VOLUMES

Enhancement of chemotherapeutic effects
Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2)
✍ Hideyuki Akaza; Hideaki Fukushima; Kenkichi Koiso; Yoshio Aso πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 496 KB πŸ‘ 1 views

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered intraperitoneally in combination with multidrug chemotherapy using methotrexate (M), vinblastine (V), doxorubicin (A), and cisplatin (C, or for the combination, MVAC) to C3H/He mice (5-week-old females) after experime

Enhanced secretion of human granulocyte
Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration
✍ Cheon Soon Bae; Doo Suk Yang; Ki Ryong Chang; Baik Lin Seong; Jeewon Lee πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 265 KB πŸ‘ 2 views

The synthesis and secretion of recombinant human granulocyte colony-stimulating factor (rhG-CSF) are investigated in fed-batch cultures at high cell concentration of recombinant Saccharomyces cerevisiae, and some important characteristics of the secreted rhG-CSF are demonstrated. Transcription of th

Pharmacokinetics of intravenous recombin
Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: Clearance increases in relation to absolute neutrophil count with repeated dosing
✍ Sturgill, Marc G.; Huhn, Richard D.; Drachtman, Richard A.; Ettinger, Alice G.; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics